J P Despres

Summary

Country: Canada

Publications

  1. ncbi Health consequences of visceral obesity
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, Sainte Foy, Canada
    Ann Med 33:534-41. 2001
  2. ncbi Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study
    J P Despres
    Lipid Research Center, CHUQ Research Center, CHUL Pavilion, Sainte Foy, Quebec, Canada
    Arterioscler Thromb Vasc Biol 20:1932-8. 2000
  3. ncbi Is the gender difference in LDL size explained by the metabolic complications of visceral obesity?
    I Lemieux
    Quebec Heart Institute, Laval Hospital Research Center, Ste Foy, Quebec, Canada
    Eur J Clin Invest 32:909-17. 2002
  4. ncbi Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?
    A Pare
    Lipid Research Center, CHUL Research Center, CHUQ, Sainte Foy, Quebec, Canada
    Obes Res 9:526-34. 2001
  5. ncbi Race differences in the response of postheparin plasma lipoprotein lipase and hepatic lipase activities to endurance exercise training in men: results from the HERITAGE Family Study
    J Bergeron
    Lipid Research Center, Laval University Medical Research Center, CHUL Pavilion, 2705, boulevard Laurier, RC 412, Quebec, G1V 4G2, Sainte Foy, Canada
    Atherosclerosis 159:399-406. 2001
  6. ncbi Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, Québec Lipid Research Center, CHUL Research Center CHUQ, and Department of Food Sciences and Nutrition, Laval University, Ste Foy, Quebec, Canada
    Diabetes Metab 29:6S53-61. 2003
  7. ncbi Inflammation and cardiovascular disease: is abdominal obesity the missing link?
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, and Department of Food Sciences and Nutrition, Laval University, Ste Foy, Quebec, Canada
    Int J Obes Relat Metab Disord 27:S22-4. 2003
  8. ncbi Effect of a low-glycaemic index--low-fat--high protein diet on the atherogenic metabolic risk profile of abdominally obese men
    J G Dumesnil
    Quebec Heart Institute, Laval Hospital Research Center, Quebec, Canada
    Br J Nutr 86:557-68. 2001
  9. ncbi Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men
    M T Berthier
    Lipid Research Center, Laval University Medical Research Center, Sainte Foy, Quebec, Canada
    Obes Res 9:668-75. 2001
  10. ncbi The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study
    J Robitaille
    Lipid Research Center, CHUL Research Center, Sainte Foy, Quebec, Canada
    Clin Genet 63:109-16. 2003

Collaborators

Detail Information

Publications14

  1. ncbi Health consequences of visceral obesity
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, Sainte Foy, Canada
    Ann Med 33:534-41. 2001
    ....
  2. ncbi Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study
    J P Despres
    Lipid Research Center, CHUQ Research Center, CHUL Pavilion, Sainte Foy, Quebec, Canada
    Arterioscler Thromb Vasc Biol 20:1932-8. 2000
    ....
  3. ncbi Is the gender difference in LDL size explained by the metabolic complications of visceral obesity?
    I Lemieux
    Quebec Heart Institute, Laval Hospital Research Center, Ste Foy, Quebec, Canada
    Eur J Clin Invest 32:909-17. 2002
    ....
  4. ncbi Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?
    A Pare
    Lipid Research Center, CHUL Research Center, CHUQ, Sainte Foy, Quebec, Canada
    Obes Res 9:526-34. 2001
    ..The aim of the present study was to examine whether the association of waist girth to visceral adipose tissue (AT) accumulation was altered by weight loss in abdominally obese men...
  5. ncbi Race differences in the response of postheparin plasma lipoprotein lipase and hepatic lipase activities to endurance exercise training in men: results from the HERITAGE Family Study
    J Bergeron
    Lipid Research Center, Laval University Medical Research Center, CHUL Pavilion, 2705, boulevard Laurier, RC 412, Quebec, G1V 4G2, Sainte Foy, Canada
    Atherosclerosis 159:399-406. 2001
    ..However, the generally better metabolic profile of Black individuals may minimize further improvement of lipoprotein-lipid concentrations by exercise training...
  6. ncbi Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, Québec Lipid Research Center, CHUL Research Center CHUQ, and Department of Food Sciences and Nutrition, Laval University, Ste Foy, Quebec, Canada
    Diabetes Metab 29:6S53-61. 2003
    ..Thus, metformin treatment may represent a relevant element of an integrated lifestyle modification-pharmacotherapy to prevent not only type 2 diabetes but also cardiovascular disease...
  7. ncbi Inflammation and cardiovascular disease: is abdominal obesity the missing link?
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, and Department of Food Sciences and Nutrition, Laval University, Ste Foy, Quebec, Canada
    Int J Obes Relat Metab Disord 27:S22-4. 2003
  8. ncbi Effect of a low-glycaemic index--low-fat--high protein diet on the atherogenic metabolic risk profile of abdominally obese men
    J G Dumesnil
    Quebec Heart Institute, Laval Hospital Research Center, Quebec, Canada
    Br J Nutr 86:557-68. 2001
    ..However, the present study was a short-term intervention and additional trials are clearly needed to document the long-term efficacy of this dietary approach with regard to compliance and effects on the metabolic risk profile...
  9. ncbi Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men
    M T Berthier
    Lipid Research Center, Laval University Medical Research Center, Sainte Foy, Quebec, Canada
    Obes Res 9:668-75. 2001
    ..This study examined the effect of this mutation on lipoprotein levels in viscerally obese hyperinsulinemic condition...
  10. ncbi The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study
    J Robitaille
    Lipid Research Center, CHUL Research Center, Sainte Foy, Quebec, Canada
    Clin Genet 63:109-16. 2003
    ..These results suggest that the PPAR-gamma P12A polymorphism can modulate the association between dietary fat intake and components of the metabolic syndrome...
  11. ncbi Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, Ste Foy Québec, Canada
    J Endocrinol Invest 29:77-82. 2006
    ....
  12. ncbi HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study
    J P Despres
    Quebec Heart Institute, Laval Hospital Research Center, Sainte Foy, Canada
    Atherosclerosis 153:263-72. 2000
    ..The objective of the present review article is to use data from the Quebec cardiovascular study to demonstrate that in men, a low HDL-cholesterol may be even more of a risk factor and a target for therapy than a high LDL-cholesterol...
  13. ncbi Contribution of CB1 blockade to the management of high-risk abdominal obesity
    J P Despres
    Quebec Heart Institute, Hôpital Laval Research Center, Quebec, Quebec, Canada
    Int J Obes (Lond) 30:S44-52. 2006
    ....
  14. ncbi Increasing high-density lipoprotein cholesterol: an update on fenofibrate
    J P Despres
    Institute de Cardiologie de l Hôpital Laval, Sainte Foy, Quebec, Canada
    Am J Cardiol 88:30N-36N. 2001
    ....